0.85% 0.02

Rocket Pharmaceuticals Inc (RCKT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	3.28% 46.92	48.51	43.96	52.25	71.15
Interest Income/Expense	0.00% 0.473	0.473	0.473	0.473	0.473
Operating Income/Loss	3.28% -46.92	-48.51	-43.96	-52.25	-71.15
Income/Loss From Continuing Operations Before Tax	131.84	-	-42.54	-50.33	-68.92
Income Tax Expense/Benefit	8.621	-	-	-	-
Net Income/Loss	358.89% 123.21	-47.59	-42.54	-50.33	-68.92
Basic Average Shares	0.63% 112.84	112.13	0.2236	111.57	111.02
Diluted Average Shares	2.12% 114.51	112.13	0.2236	111.57	111.02
Basic Earnings Per Share	359.52% 1.09	-0.42	-0.38	-0.45	-0.62
Diluted Earnings Per Share	357.14% 1.08	-0.42	-0.38	-0.45	-0.62

GYRE

$6.17

0.00%

ACHV

$6.465

0.69%

CADL

$8.73

1.04%

DNA

$9.96

1.01%

AURA

$6.515

0.69%

WVE

$3.435

0.44%